Overall rank by patents
#5,320
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Seven Bridges Genomics Inc.
USPTO PatentsView assignee record — 65 granted patents across 11 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY).
65
Total patents granted
11
CPC technology areas
18.6
Avg claims per patent
+110%
5-year filing velocity
Portfolio overview
Seven Bridges Genomics Inc. has been granted 65 US utility patents between 2015 and 2025, placing Seven Bridges Genomics Inc. at rank #5,320 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY). As a US Corporation, Seven Bridges Genomics Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 42.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 44 grants, compared with 21 in the 2015–2019 window — a +110% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Seven Bridges Genomics Inc.'s 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Seven Bridges Genomics Inc. against peers pursuing similar technology classes.
How does Seven compare?
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
- Samsung
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
- International Bus…
International Business Machines Corporation
72,926 patents
- Canon 34,378
Canon Kabushiki Kaisha
34,378 patents
- LG 32,607
LG ELECTRONICS INC.
32,607 patents
- Taiwan Semiconduc… 31,041
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
- Apple 30,560
Apple Inc.
30,560 patents
- Qualcomm Incorpor… 30,354
QUALCOMM Incorporated
30,354 patents
- Intel 27,498
Intel Corporation
27,498 patents
- Seven Bridges Gen… ◀ 65
Seven Bridges Genomics Inc.
65 patents
What this shows Seven holds 65 patents — placing it at rank #5,320 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
USPTO utility patent grants by year · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 4.6% |
| 2016 | 1 | 1.5% |
| 2017 | 2 | 3.1% |
| 2018 | 6 | 9.2% |
| 2019 | 9 | 13.8% |
| 2020 | 13 | 20.0% |
| 2021 | 7 | 10.8% |
| 2022 | 8 | 12.3% |
| 2023 | 8 | 12.3% |
| 2024 | 5 | 7.7% |
| 2025 | 3 | 4.6% |
Which technologies does Seven Bridges Genomics Inc. patent most?
Top 11 of 11 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Seven Bridges Genomics Inc. hold?
Seven Bridges Genomics Inc. holds 65 US granted patents filed between 2015 and 2025, spanning 11 technology areas.
What is Seven Bridges Genomics Inc.'s Innovation Score?
Seven Bridges Genomics Inc. has an Innovation Score of 42.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Seven Bridges Genomics Inc. focus on?
Seven Bridges Genomics Inc.'s top technology area is G16B (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY) with 60 patents. The company has filed patents in 11 CPC subclasses total.
Is Seven Bridges Genomics Inc.'s patent filing rate increasing or decreasing?
Seven Bridges Genomics Inc.'s recent filing velocity is +110% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Seven Bridges Genomics Inc.'s patents?
Seven Bridges Genomics Inc.'s patents average 18.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Seven Bridges Genomics Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
Learn More
Explore the patent dataset
G16B technology
Seven Bridges Genomics Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders
See where Seven Bridges Genomics Inc. ranks among the largest US patent assignees
All technology classes
Browse every CPC technology area by patent activity
How the score works
The four dimensions behind the Innovation Score
Related
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
All federal data sources used on this page
- USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
- USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
- USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
- USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
- SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
- WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope
